E. S. Kim et al. / Tetrahedron Letters 51 (2010) 4648–4652
4651
9. For the introduction of nucleophiles at the secondary position of Baylis–
Hillman adducts, see Kim, E. S.; Kim, K. H.; Kim, S. H.; Kim, J. N. Tetrahedron Lett.
2009, 50, 5098–5101. and further references cited therein.
In summary, we disclosed an efficient synthesis of dihydroinde-
nofu rans starting from the Baylis–Hillman adducts via the Pd-cat-
alyzed 5-endo-trig-carbopalladation and enolate O-alkylation
cascade as a key step. This is the first example of enolate O-alkyl-
ation with a C(sp3)-bound palladium intermediate.
10. Typical procedure for the synthesis of 3a: To a solution of 1a (668 mg, 2.0 mmol)
in CH3CN (5 mL) was added DABCO (246 mg, 2.2 mmol) and the reaction
mixture was stirred at room temperature for 30 min. Deoxybenzoin (2a,
470 mg, 2.4 mmol) and NaOH (96 mg, 2.4 mmol) were added to the solution
and the reaction mixture was stirred at room temperature for 48 h. After the
usual aqueous workup and column chromatographic purification process
(hexanes/CH2Cl2/diethyl ether, 15:1:1) 3a was isolated as a syn/anti (2:1)
mixture, 763 mg, (85%). Other starting materials 3b–k were prepared similarly,
and compounds 3c–h and 3k were isolated as syn/anti mixtures. Selected
spectroscopic data of 3a, 3b, and 3i are as follows. Analytically pure samples of
major-3a and minor-3a were obtained by careful column chromatography, and
the stereochemistry was not confirmed.
Acknowledgments
This work was supported by the National Research Foundation
of Korea Grant funded by the Korean Government (2010-0015675).
Spectroscopic data were obtained from the Korea Basic Science
Institute, Gwangju branch.
Compound 3a (major): white solid, mp 157–159 °C; IR (KBr) 1722, 1680,
1268 cmÀ1 1H NMR (CDCl3, 300 MHz) d 3.64 (s, 3H), 5.40–5.49 (m, 2H), 5.78 (s,
;
1H), 6.28 (s, 1H), 6.91 (t, J = 7.8 Hz, 1H), 7.04–7.09 (m, 3H), 7.11–7.21 (m, 3H),
7.28 (d, J = 7.8 Hz, 1H), 7.37–7.43 (m, 3H), 7.47–7.52 (m, 1H), 7.98–8.01 (m,
2H); 13C NMR (CDCl3, 75 MHz) d 48.16, 51.77, 57.11, 125.44, 126.02, 126.94,
127.22, 127.93, 128.23, 128.49, 128.58, 129.23, 129.56, 132.93, 133.01, 135.12,
136.64, 138.84, 141.43, 166.63, 197.81; ESIMS m/z 449 (M++1), 451 (M++3).
Anal. Calcd for C25H21BrO3: C, 66.82; H, 4.71. Found: C, 67.03; H, 4.82.
Compound 3a (minor): white solid, mp 127–129 °C; IR (KBr) 1717, 1682,
References and notes
1. For the Pd-catalyzed intermolecular C-arylation of ketone enolate, see: (a)
Hamann, B. C.; Hartwig, J. F. J. Am. Chem. Soc. 1997, 119, 12382–12383; (b)
Kawatsura, M.; Hartwig, J. F. J. Am. Chem. Soc. 1999, 121, 1473–1478; (c) Fox, J.
M.; Huang, X.; Chieffi, A.; Buchwald, S. L. J. Am. Chem. Soc. 2000, 122, 1360–
1370; (d) Culkin, D. A.; Hartwig, J. F. Organometallics 2004, 23, 3398–3416.
2. For the Pd-catalyzed intermolecular C-arylation of ester enolate or malonate,
see: (a) Moradi, W. A.; Buchwald, S. L. J. Am. Chem. Soc. 2001, 123, 7996–8002;
(b) Lee, S.; Beare, N. A.; Hartwig, J. F. J. Am. Chem. Soc. 2001, 123, 8410–8411; (c)
Aramendia, M. A.; Borau, V.; Jimenez, C.; Marinas, J. M.; Ruiz, J. R.; Urbano, F. J.
Tetrahedron Lett. 2002, 43, 2847–2849.
3. For the Pd-catalyzed intramolecular O-arylation of enolate, see: (a) Willis, M.
C.; Taylor, D.; Gillmore, A. T. Org. Lett. 2004, 6, 4755–4757; (b) Willis, M. C.;
Taylor, D.; Gillmore, A. T. Tetrahedron 2006, 62, 11513–11520; (c) Churruca, F.;
SanMartin, R.; Tellitu, I.; Dominguez, E. Eur. J. Org. Chem. 2005, 2481–2490; (d)
Terao, Y.; Satoh, T.; Miura, M.; Nomura, M. Bull. Chem. Soc. Jpn. 1999, 72, 2345–
2350; (e) Eidamshaus, C.; Burch, J. D. Org. Lett. 2008, 10, 4211–4214; (f)
Tenaglia, A.; Kammerer, F. Synlett 1996, 576–578; (g) Millemaggi, A.; Perry, A.;
Whitwood, A. C.; Taylor, R. J. K. Eur. J. Org. Chem. 2009, 2947–2952;
Intermolecular trapping of an acylpalladium intermediate with an O-enolate
has been reported, see: (h) Tadd, A. C.; Fielding, M. R.; Willis, M. C. Chem.
Commun. 2009, 6744–6746; (i) Negishi, E.-I.; Liou, S.-Y.; Xu, C.; Shimoyama, I.;
Makabe, H. J. Mol. Catal. A: Chem. 1999, 143, 279–286.
4. For the general review on Baylis–Hillman reaction, see: (a) Basavaiah, D.; Rao,
A. J.; Satyanarayana, T. Chem. Rev. 2003, 103, 811–891; (b) Singh, V.; Batra, S.
Tetrahedron 2008, 64, 4511–4574; (c) Kim, J. N.; Lee, K. Y. Curr. Org. Chem. 2002,
6, 627–645; (d) Lee, K. Y.; Gowrisankar, S.; Kim, J. N. Bull. Korean Chem. Soc.
2005, 26, 1481–1490; (e) Radha Krishna, P.; Sachwani, R.; Reddy, P. S. Synlett
2008, 2897–2912; (f) Declerck, V.; Martinez, J.; Lamaty, F. Chem. Rev. 2009, 109,
1–48; (g) Gowrisankar, S.; Lee, H. S.; Kim, S. H.; Lee, K. Y.; Kim, J. N. Tetrahedron
2009, 65, 8769–8780.
5. For our recent contributions on Pd-catalyzed reactions of modified Baylis–
Hillman adducts, see: (a) Kim, K. H.; Lee, H. S.; Kim, S. H.; Kim, S. H.; Kim, J. N.
Chem. Eur. J. 2010, 16, 2375–2380; (b) Lee, H. S.; Kim, S. H.; Kim, T. H.; Kim, J. N.
Tetrahedron Lett. 2008, 49, 1773–1776; (c) Gowrisankar, S.; Lee, H. S.; Kim, J. M.;
Kim, J. N. Tetrahedron Lett. 2008, 49, 1670–1673; (d) Gowrisankar, S.; Lee, H. S.;
Lee, K. Y.; Lee, J.-E.; Kim, J. N. Tetrahedron Lett. 2007, 48, 8619–8622; (e) Lee, H.
S.; Kim, S. H.; Gowrisankar, S.; Kim, J. N. Tetrahedron 2008, 64, 7183–7190; (f)
Kim, H. S.; Gowrisankar, S.; Kim, S. H.; Kim, J. N. Tetrahedron Lett. 2008, 49,
3858–3861; (g) Kim, H. S.; Lee, H. S.; Kim, S. H.; Kim, J. N. Tetrahedron Lett. 2009,
50, 3154–3157.
6. For the synthesis of dihydrofuran moiety-containing tricyclic natural products,
see: (a) Malona, J. A.; Cariou, K.; Frontier, A. J. J. Am. Chem. Soc. 2009, 131, 7560–
7561; (b) Giese, M. W.; Moser, W. H. Org. Lett. 2008, 10, 4215–4218; (c) Li, H.;
Fu, B.; Wang, M. A.; Li, N.; Liu, W. J.; Xie, Z. Q.; Ma, Y. Q.; Qin, Z. Eur. J. Org. Chem.
2008, 1753–1758; (d) Sous, M. E.; Khoo, M. L.; Holloway, G.; Owen, D.;
Scammells, P. J.; Rizzacasa, M. A. Angew. Chem., Int. Ed. 2007, 46, 7835–7838; (e)
Adams, T. E.; Sous, M. E.; Hawkins, B. C.; Himer, S.; Holloway, G.; Khoo, M. L.;
Owen, D. J.; Savage, G. P.; Scammells, P. J.; Rizzacasa, M. A. J. Am. Chem. Soc.
2009, 131, 1607–1616; (f) Gerard, B.; Cencic, R.; Pelletier, J.; Porco, J. A., Jr.
Angew. Chem., Int. Ed. 2007, 46, 7831–7834.
7. For the examples of dihydrofuran moiety-containing polycyclic compounds,
see: (a) Lee, Y. R.; Kim, B. S.; Kim, D. H. Tetrahedron 2000, 56, 8845–8853; (b)
Sajimon, M. C.; Ramaiah, D.; Thomas, K. G.; George, M. V. J. Org. Chem. 2001, 66,
3182–3187; (c) Venkata, N.; Mudiganti, S.; Claessens, S.; De Kimpe, N.
Tetrahedron 2009, 65, 1716–1723; (d) Azuma, T.; Tanaka, Y.; Kikuzaki, H.
Phytochemistry 2008, 69, 2743–2748; (e) Na, J. E.; Lee, K. Y.; Seo, J.; Kim, J. N.
Tetrahedron Lett. 2005, 46, 4505–4508; (f) Almog, J.; Rozin, R.; Klein, A.;
Shamuilov-Levinton, G.; Cohen, S. Tetrahedron 2009, 65, 7954–7962.
8. The cinnamyl bromides were prepared by treatment of the Baylis–Hillman
alcohols with aqueous HBr according to the literature procedure, see: (a)
Buchholz, R.; Hoffmann, H. M. R. Helv. Chim. Acta 1991, 74, 1213–1220; (b)
Ameer, F.; Drewes, S. E.; Emslie, N. D.; Kaye, P. T.; Mann, R. L. J. Chem. Soc.,
Perkin Trans. 1 1983, 2293–2295; (c) Gowrisankar, S.; Kim, S. H.; Kim, J. N. Bull.
Korean Chem. Soc. 2009, 30, 726–728. and further references cited therein; (d)
Basavaiah, D.; Reddy, K. R.; Kumaragurubaran, N. Nat. Protocols 2007, 2, 2665–
2676.
1438 cmÀ1 1H NMR (CDCl3, 300 MHz) d 3.55 (s, 3H), 5.18 (d, J = 11.7 Hz, 1H),
;
5.61 (s, 1H), 5.91 (d, J = 11.7 Hz, 1H), 6.03 (s, 1H), 6.98 (t, J = 7.8 Hz, 1H), 7.11 (t,
J = 7.8 Hz, 1H), 7.16–7.22 (m, 1H), 7.25–7.48 (m, 7H), 7.52–7.60 (m, 2H), 7.92–
7.95 (m, 2H); 13C NMR (CDCl3, 75 MHz) d 51.06, 51.51, 55.72, 125.91, 127.17,
127.49, 128.04, 128.50 (2C), 128.55, 128.83, 129.16, 129.74, 132.90, 133.48,
136.65, 136.73, 138.77, 139.67, 166.67, 197.71; ESIMS m/z 449 (M++1), 451
(M++3).
Compound 3b: 56%; colorless oil; IR (film) 1720, 1686, 1438 cmÀ1 1H NMR
;
(CDCl3, 300 MHz) d 3.43 (dd, J = 17.4 and 7.5 Hz, 1H), 3.60 (dd, J = 17.4 and
7.5 Hz, 1H), 3.70 (s, 3H), 5.12 (t, J = 7.5 Hz, 1H), 5.51 (s, 1H), 6.39 (s, 1H), 7.05–
7.10 (m, 1H), 7.21–7.27 (m, 2H), 7.42–7.48 (m, 2H), 7.53–7.59 (m, 2H), 7.93–
7.99 (m, 2H); 13C NMR (CDCl3, 75 MHz) d 41.41, 42.35, 51.99, 124.93, 126.06,
127.43, 128.06, 128.22, 128.34, 128.61, 133.19, 133.39, 136.57, 140.83, 141.18,
166.75, 197.03; ESIMS m/z 373 (M++1), 375 (M++3).
Compound 3i: 83%; colorless oil; IR (film) 1723, 1700, 1437 cmÀ1 1H NMR
;
(CDCl3, 300 MHz) d 1.95 (s, 3H), 2.24 (s, 3H), 3.68 (s, 3H), 4.92 (d, J = 12.3 Hz,
1H), 5.17 (d, J = 12.3 Hz, 1H), 5.93 (s, 1H), 6.30 (s, 1H), 7.07 (t, J = 7.8 Hz, 1H),
7.25 (t, J = 7.8 Hz, 1H), 7.39 (d, J = 7.8 Hz, 1H), 7.55 (d, J = 7.8 Hz, 1H); 13C NMR
(CDCl3, 75 MHz) d 29.35, 29.76, 46.19, 51.96, 71.92, 125.35, 127.69, 128.80,
128.88, 129.65, 133.76, 137.25, 138.25, 166.28, 202.11, 202.54; ESIMS m/z 353
(M++1), 355 (M++3).
Typical procedure for the synthesis of 4a: A mixture of 3a (450 mg, 1.0 mmol),
Pd(OAc)2 (22 mg, 10 mol %), PPh3 (52 mg, 20 mol %), and Cs2CO3 (652 mg,
2.0 mmol) in toluene (3 mL) was heated to reflux for 1 h. After the usual
aqueous workup and column chromatographic purification process (hexanes/
CH2Cl2/diethyl ether, 5:1:1), 4a was isolated as a white solid, 210 mg (57%).
Other compounds 4b–k were prepared similarly, and the selected
spectroscopic data of 4a–c, 4g, 4i, and 4k are as follows.
Compound 4a: 57%; pale yellow solid, mp 116–118 °C; IR (KBr) 1755, 1737,
1237 cmÀ1 1H NMR (CDCl3, 300 MHz) d 3.64 (d, J = 17.4 Hz, 1H), 3.85 (s, 3H),
;
3.86 (d, J = 17.4 Hz, 1H), 5.21 (s, 1H), 6.72 (d, J = 7.2 Hz, 1H), 7.02 (t, J = 7.2 Hz,
1H), 7.17–7.24 (m, 4H), 7.25–7.34 (m, 6H), 7.37–7.42 (m, 2H); 13C NMR (CDCl3,
75 MHz) d 44.52, 52.87, 63.72, 92.24, 112.77, 124.19, 124.85, 126.88, 126.97,
127.62, 127.67, 127.99, 128.53, 128.57, 129.36, 130.89, 134.09, 139.48, 141.89,
149.42, 173.66; ESIMS m/z 391 (M++Na). Anal. Calcd for C25H20O3: C, 81.50; H,
5.47. Found: C, 81.29; H, 5.61.
Compound 4b: 42%; colorless oil; IR (film) 1735, 1244, 1207 cmÀ1 1H NMR
;
(CDCl3, 300 MHz) d 3.56 (d, J = 17.7 Hz, 1H), 3.82 (s, 3H), 3.86 (d, J = 17.7 Hz,
1H), 4.85 (d, J = 3.3 Hz, 1H), 5.57 (d, J = 3.3 Hz, 1H), 7.20–7.34 (m, 7H), 7.56–
7.59 (m, 2H); 13C NMR (CDCl3, 75 MHz) d 44.56, 52.76, 60.14, 94.06, 97.38,
123.88, 125.14, 125.48, 127.46, 127.50, 128.20, 128.69, 130.24, 139.35, 143.02,
155.98, 173.66; ESIMS m/z 293 (M++1). Anal. Calcd for C19H16O3: C, 78.06; H,
5.52. Found: C, 78.33; H, 5.49.
Compound 4c: 62%; colorless oil; IR (firm) 2239, 1655, 1261 cmÀ1 1H NMR
;
(CDCl3, 300 MHz) d 3.87 (d, J = 17.7 Hz, 1H), 3.94 (d, J = 17.7 Hz, 1H), 5.32 (s,
1H), 6.72 (d, J = 7.8 Hz, 1H), 7.10 (t, J = 7.8 Hz, 1H), 7.21–7.28 (m, 4H), 7.30–7.42
(m, 8H); 13C NMR (CDCl3, 75 MHz) d 45.70, 65.47, 82.29, 113.05, 119.94,
124.19, 124.96, 127.41, 127.58, 127.68, 128.08, 128.29, 128.84, 129.03, 129.45,
129.80, 133.00, 137.53, 140.05, 148.91; ESIMS m/z 336 (M++1). Anal. Calcd for
C
24H17NO: C, 85.94; H, 5.11; N, 4.18. Found: C, 85.67; H, 5.35; N, 4.08.
Compound 4g: 74%; white solid, mp 57–59 °C; IR (KBr) 1742, 1705, 1648 cmÀ1
;
1H NMR (CDCl3, 300 MHz) d 2.22 (s, 3H), 3.47 (d, J = 17.7 Hz, 1H), 3.77 (d,
J = 17.7 Hz, 1H), 3.81 (s, 3H), 3.82 (s, 3H), 4.92 (s, 1H), 7.22–7.26 (m, 3H), 7.52–
7.56 (m, 1H); 13C NMR (CDCl3, 75 MHz) d 14.33, 43.52, 50.96, 52.89, 58.55,
94.47, 105.65, 124.66, 125.26, 127.56, 127.84, 138.70, 142.46, 165.69, 168.33,
172.26; ESIMS m/z 289 (M++1). Anal. Calcd for C16H16O5: C, 66.66; H, 5.59.
Found: C, 66.95; H, 5.77.
Compound 4i:81%;colorlessoil; IR (film)1751, 1625, 1385 cmÀ1;1HNMR (CDCl3,
300 MHz) d 2.26 (s, 3H), 2.35 (s, 3H), 3.47 (d, J = 17.7 Hz, 1H), 3.77 (d, J = 17.7 Hz,
1H), 3.80 (s, 3H), 5.03 (s, 1H), 7.18–7.24 (m, 3H), 7.51–7.54 (m, 1H); 13C NMR
(CDCl3, 75 MHz) d 15.59, 29.44, 43.29, 52.87, 59.21, 93.91, 118.06, 124.49,
125.82, 127.65, 127.75, 138.48, 142.74, 166.87, 172.14, 193.07; ESIMS m/z 273